Capital One National Association’s AstraZeneca AZN Stock Holding History

Capital One National Association’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-3,456	Closed	-$242K	–	491
2018 Q1	$242K	Buy	3,456 +29	+0.8%	+$2.01K	0.02%	463
2017 Q4	$238K	Buy	3,427 +435	+15%	+$29.3K	0.02%	474
2017 Q3	$203K	Buy	2,992 +19	+0.6%	+$1.2K	0.01%	507
2017 Q2	$203K	Buy	+2,973	New	+$194K	0.01%	498

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

Capital One National Association's AZN Position: Q2 2018 in Review

Capital One National Association sold out of AstraZeneca (AZN) in Q2 2018, closing a stake of 3,456 shares — an estimated $242K sold.

Capital One National Association first reported a position in AZN in Q2 2017 and held it in 4 quarters. The position peaked at $242K in Q1 2018. 530 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

Capital One National Association reported no remaining AstraZeneca position as of Q2 2018 after selling out during the quarter.
Capital One National Association sold 3,456 AstraZeneca shares in Q2 2018, an estimated $242K.
Capital One National Association first reported a position in AstraZeneca in Q2 2017 and held it in 4 quarters.
Capital One National Association's AstraZeneca position peaked at $242K in Q1 2018.
530 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on Capital One National Association's 13F filing for Q2 2018, filed 16 Jul 2018.